BEIJING FOYOU PHARMA CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.9 CNY | -1.24% |
|
+1.02% | -7.77% |
| Sales 2022 | 3.24B 449M 35.83B | Sales 2023 | 3.34B 462M 36.93B | Capitalization | 8.28B 1.15B 91.5B |
|---|---|---|---|---|---|
| Net income 2022 | 438M 60.63M 4.84B | Net income 2023 | 489M 67.69M 5.41B | EV / Sales 2022 | 1.52 x |
| Net cash position 2022 | 2.42B 335M 26.74B | Net cash position 2023 | 2.41B 333M 26.61B | EV / Sales 2023 | 1.76 x |
| P/E ratio 2022 |
14.7
x | P/E ratio 2023 |
16.9
x | Employees | 3,436 |
| Yield 2022 |
2.61% | Yield 2023 |
2.9% | Free-Float | 22.27% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.24% | ||
| 1 week | +1.02% | ||
| Current month | +1.02% | ||
| 1 month | +8.38% | ||
| 3 months | +13.17% | ||
| 6 months | -14.15% | ||
| Current year | -7.77% |
1 week
15.81
16.24
1 month
14.1616.24
Current year
12.1318.12
1 year
12.1319.62
3 years
12.1323.16
5 years
12.1323.16
10 years
12.1323.16
| Managers | Title | Age | Since |
|---|---|---|---|
He Huang
CEO | Chief Executive Officer | 56 | 15/05/19 |
Xu Yan Yang
DFI | Director of Finance/CFO | 44 | 15/05/19 |
Jian Tao Yang
BRD | Director/Board Member | 53 | 15/05/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jin Chen
BRD | Director/Board Member | 56 | 13/06/19 |
Bai Fan Hu
BRD | Director/Board Member | 62 | 15/05/19 |
Xin Rong Cui
BRD | Director/Board Member | 60 | 15/05/19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 15.9 | -1.24% | 3,122,100 |
| 09/05/24 | 16.1 | +0.44% | 2,764,800 |
| 08/05/24 | 16.03 | -0.31% | 3,014,249 |
| 07/05/24 | 16.08 | -0.25% | 3,270,249 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotes
Beijing Foyou Pharma Co Ltd, formerly Beijing Winsunny Pharmaceutical Co Ltd, is a China-based company mainly engaged in the research, development, production and sales of pharmaceutical preparations and medical devices. The Company's pharmaceutical preparations mainly cover the fields of cardiovascular system, chronic kidney disease, skin disease, digestive system, diabetes, mental nervous system, gynecology and others. The Company's pharmaceutical preparation products mainly include tablets, ointments, creams, gels, soft capsules, solutions, syrups, tinctures, sprays, hard capsules and others. The Company's medical device business focuses on humidification and oxygen inhalation devices, and its main products include disposable oxygen inhalation tubes and others. The Company mainly operates its businesses in the domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
12/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.77% | 1.03B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- 601089 Stock
